We are delighted to announce that SHIFTBIO INC participated in the ‘Biocom Global Partnering' event held in San Diego, USA, on February 26th. With over 400 companies worldwide in attendance, SHIFTBIO INC showcased its innovative platform technology and engaged in discussions with global pharmaceutical companies and investors for potential pipeline deals.
It was a profoundly meaningful experience engaging with investors who resonate with SHIFTBIO's vision of providing patients with rare and intractable diseases another chance through the development of therapeutics. Additionally, exchanging insights with companies that have entered the global market was invaluable. Stay tuned for our upcoming journey!
We are delighted to announce that SHIFTBIO INC participated in the ‘Biocom Global Partnering' event held in San Diego, USA, on February 26th. With over 400 companies worldwide in attendance, SHIFTBIO INC showcased its innovative platform technology and engaged in discussions with global pharmaceutical companies and investors for potential pipeline deals.
It was a profoundly meaningful experience engaging with investors who resonate with SHIFTBIO's vision of providing patients with rare and intractable diseases another chance through the development of therapeutics. Additionally, exchanging insights with companies that have entered the global market was invaluable. Stay tuned for our upcoming journey!